Weekly Recap | CHINARES PHARMA -3.95%, consensus target above spotWeekly Review·Sep 12, 2026 at 05:48 AM03320+2.23%
Weekly Recap | CHINARES PHARMA -0.78%, most brokers rate it buyWeekly Review·Sep 5, 2026 at 05:27 AM03320+2.23%
This afternoon, appointment reservations opened for the pilot program of internet diagnosis and treatment in BeijingWallstreetcn·Jan 31, 2026 at 04:07 AM512010+1.60%01099+3.85%
